Immunotherapy Biomarkers: Overcoming the Barriers Symposium - TCR Sequencing Technology PlatformApril 2016Bethesda, MDSummaryIn this slide presentation from "Immunotherapy Biomarkers: Overcoming the Barriers" Symposium in Bethesda MD in April 2016, Dr. Ilan Kirsh, MD (Senior Vice President, Adaptive Biotechnologies Corp.) explains the capabilities and applications of high-throughput PCR-based immunosequencing technology for clonality assessment, clone tracking and mutation detection.Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.#Industry #Researcher #Biomarkers #Pharmacist #Oncologist #PresentationSlides#SITC #ColonCancer #Melanoma #AlliedHealth #Clinician #2016
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us